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Abstract: Missing values are known to be problematic for the analysis of gas 
chromatography-mass spectrometry (GC-MS) metabolomics data. Typically these values 
cover about 10%–20% of all data and can originate from various backgrounds, including 
analytical, computational, as well as biological. Currently, the most well known substitute 
for missing values is a mean imputation. In fact, some researchers consider this aspect of 
data analysis in their metabolomics pipeline as so routine that they do not even mention 
using this replacement approach. However, this may have a significant influence on the 
data analysis output(s) and might be highly sensitive to the distribution of samples between 
different classes. Therefore, in this study we have analysed different substitutes of missing 
values namely: zero, mean, median, k-nearest neighbours (kNN) and random forest (RF) 
imputation, in terms of their influence on unsupervised and supervised learning and, thus, 
their impact on the final output(s) in terms of biological interpretation. These comparisons 
have been demonstrated both visually and computationally (classification rate) to support 
our findings. The results show that the selection of the replacement methods to impute missing 
values may have a considerable effect on the classification accuracy, if performed incorrectly 
this may negatively influence the biomarkers selected for an early disease diagnosis or 
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identification of cancer related metabolites. In the case of GC-MS metabolomics data  
studied here our findings recommend that RF should be favored as an imputation of missing  
value over the other tested methods. This approach displayed excellent results in terms of 
classification rate for both supervised methods namely: principal components-linear 
discriminant analysis (PC-LDA) (98.02%) and partial least squares-discriminant analysis 
(PLS-DA) (97.96%) outperforming other imputation methods. 
Keywords: missing values; metabolomics; unsupervised learning; supervised learning 
 
1. Introduction 
Metabolomics is the study of all metabolites in a biological system under a given set of conditions [1]. 
The classical technologies for the analysis of metabolites (i.e., chemical entities) include: Gas 
chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), 
capillary electrophoresis-mass spectrometry (CE-MS), nuclear magnetic resonance (NMR) spectroscopy, 
Fourier transform-infrared (FT-IR) spectroscopy, and many more [2]. These methods have been 
widely applied in countless metabolomics research studies. These include for example: cell line studies 
probing intracellular metabolites [3]; animal models for cancer study, such as mouse tumours [4];  
as well as general metabolic profiling for the analysis of human serum [5]. Unfortunately not all  
of these methods generate a complete data set, for instance GC-MS and LC-MS analyses employ 
chromatographic separation prior to MS and thus require a complex deconvolution step to transform 
these 3D data matrices into lists of annotated features (metabolites) with (relative) abundances. The 
result of this process is often a matrix that is not fully populated and thus presents a major problem  
in data processing due to these missing values [6]. 
We believe that one of the most important steps in GC-MS data pre-processing of metabolomics 
data, next to peak detection and alignment, is handling missing values [7]. In our experience, typically 
10%–20% of GC-MS data from an experiment are missing, with the same level of missing values also 
reported in many other studies (e.g., Hrydziuszko and Viant (2011) [8] and Xia et al. (2009) [9]). 
Whilst it is obvious that a missing value is when a matrix contains an empty cells usually recorded as 
―Not a Number‖ (NaN) or more worryingly as a zero which cannot be readily distinguished from the 
real absence of a feature rather than a failure in the analysis. The obvious question that arises from 
these observations is: What are the roots of these missing values? Prior to any analysis it is good 
practice to identify the origins of missing values whether they are truly missing or not [10]. Missing 
values may arise due to various reasons, such as: (1) limits in computational detection; (2) imperfection of 
the algorithms whereby they fail in the identification of some of the signals from the background; (3) 
low intensity of the signals used; (4) measurement error; and finally (5) deconvolution that may result 
in false negative during separation of overlapping signals [6,8,10–17]. 
Currently, the most well-known substitute for missing values is their substitution with a mean value [6]. 
In fact, some researchers do not specifically state how this aspect of data analysis in their metabolomics 
pipeline has been performed and use this replacement approach as a common practice. This is despite 
the fact that this problem has been well recognised in the literature as an important aspect and also 
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appears within the minimum reporting standards for data analysis for metabolomics [7]. Methods which 
have been reported in the literature include: replacing missing values by half of the minimum  
value found in the data set [9]; missing value imputation using probabilistic principal component analysis 
(PPCA) [15], Bayesian PCA (BPCA) [18] or singular value decomposition imputation (SVDImpute) [9]; 
replacing missing value by means of nearest neighbours [6]; or replacing the missing values with zeros [19]. 
Whilst many unsupervised and supervised learning for the analysis of high dimensional metabolomics 
data require a complete dataset [2,6,7,20]. Consequently, there is a need to analyse and identify correct 
approaches for the replacement of missing values. Nevertheless, this seemingly important aspect of 
data pre-processing has not received wide attention in this field. Herein, we investigate this problem 
using a common set of metabolomics data produced using GC-MS which contained ~15% missing 
values, where the goal of the study was to analyse cancer cell lines in terms of changes in oxygen level 
and which metabolite features change during this process [21]. Therefore, we evaluated five relatively 
simple potential missing values substitutes—zero, mean, median, k-nearest neighbours (kNN) [22] and 
random forest (RF) [23] replacements—in terms of their influence on unsupervised and supervised 
learning and thus their impact on the final output(s); these outputs are related to cluster compactness 
from replicate biological measurements. Moreover, to our knowledge these approaches have not been 
compared directly for the analysis of GC-MS data. 
2. Experimental Section 
2.1. Materials and Methods 
2.1.1. Cell Culture and Experimental Protocol 
The methods used for cell culture have previously been described [21]. Experimental analysis 
proceeded as follows: MDA-MB-231 cells were seeded and allowed to adhere for 24 h in 95% air and 
5% CO2. Cells were divided into three groups: one group was placed in a 95% air and 5% CO2 incubator 
(normoxia); one group placed in a 1% O2, 5% CO2 balanced with N2 hypoxybox (hypoxia) and one 
group was placed in an anoxic chamber (Bactron anaerobic chamber, Sheldon Manufacturing, 
Cornelius, OR, USA) where 5% CO2, 5% H2 and 90% N2 (BOC, Manchester, UK) was flowed over  
a palladium catalyst to remove any remaining oxygen (anoxia) for 24 h. Each of the three groups were 
split into three sub groups, which were dosed with 0, 0.1 or 1 µM doxorubicin for 16 h whilst remaining 
in the predefined oxygen condition for a further 24 h. 
2.1.2. Methanol Metabolite Extraction 
Metabolites were extracted whilst cells remained in the predefined oxygen condition. The hypoxybox 
was sealed and cycled into the anoxic chamber prior to the extraction of metabolites. Extracellular 
medium was decanted and cells were washed with three 1 mL aliquots of PBS. A total of 1 mL of 
methanol (−48 °C) was added to each dish to quench the metabolism [24]. Cell scrappers detached 
adherent cells from the Petri dish allowing the intracellular metabolites to be extracted into the 
methanol. The solution was transferred into a pre-weighed Eppendorf tube followed by three freeze 
thaw cycles (frozen using liquid nitrogen). Cells were centrifuged at 17,000 × g for 15 min to separate 
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the pellet from the supernatant. The supernatant was transferred into a fresh Eppendorf tube and the 
pellet was lyophilised and weighed. The volume of supernatant lyophilised was normalised according 
to the dry weight of the pellet for intracellular samples. A QC was produced using 150 µL of remaining 
supernatant from each sample. Aliquots (1 mL) of the QC solution were placed into Eppendorf tubes. 
Both the sample and QC were lyophilised. 
2.1.3. Metabolic Profiling Using GC-MS and Raw Data Processing 
A total of 8 randomised batches were analysed using GC-MS. Of these batches, 7 contained 40 samples 
and 9 QCs each and 1 batch contained 30 samples and 9 QCs. Samples were analysed on an Agilent 
6890 GC (Agilent Technologies, Stockport, UK) coupled to a LECO Pegasus III (Leco Corp., St. Joseph, 
MO, USA) EI-ToF-MS. The GC-MS instrument setup used has been previously described [5,25].  
QCs were used to condition the GC-MS before sample injection. A total of 5 injections of QC samples 
were performed prior to analysing samples to normalise the chromatographic conditions to the sample 
matrix. Every 5 sample injections were followed with a single QC injection. In addition, three QC injections 
were made at the end of each analysis. These QC samples were compared to account for the system 
stability in each batch analysed. Briefly, the temperature was set at 70 °C for 4 min followed by a  
20 °C increase every min until 300 °C was reached and stabilised for 4 min. Samples (2 μL) were 
injected onto the column. The mass spectrometer was operated from m/z 45-600. The total duration per 
sample was 25 min. 
The processing of raw GC-MS data were performed following the methods described previously, 
using the LECO ChromaToF v3.25 software package to apply the chromatographic deconvolution 
algorithm [5,25]. Chromatographic peaks from the QC samples selected from each analytical block 
were manually integrated and added to a database, which included the peak area, the retention index 
and mass spectrum to compile a reference database. This reference database was manually inspected to 
ensure the mass spectra had the required fragmentation patterns and met the criteria for signal-to-noise 
(S/N) ratio and chromatographic peak width. Metabolites with fewer than 50% of features detected in 
the QC were removed [26]. 
Identification of metabolites within the compiled database was performed through searching against 
an in-house mass spectral and retention index library as described previously, where a high confidence 
match was assigned when the mass spectral match was greater than 80% and the retention index was 
within 30 [27]. All other matches that did not meet this specification were not regarded as a high 
confidence match. The metabolite library was previously developed in-house from authentic standards 
at the University of Manchester. Metabolites that were not identified in the in-house database were 
searched against the Golm metabolome database [28] and a similar match score to the in-house 
database was applied.  
In this dataset, 102 peaks were integrated from the GC chromatogram of which 45% were unidentified 
peaks; these unidentified peaks were removed from the data matrix. The coefficient of variation (CV) 
was calculated for metabolites detected in QC samples. Two metabolites with CV > 30% were removed 
from the whole data matrix as these were considered to have poor reproducibility [26]. We followed 
the metabolite identification protocols outlined by the metabolomics standards initiative [29] where the 
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in-house matches are MSI level 1 (43 metabolites) and all other identification in this manuscript to 
MSI level 2 (9 metabolites). 
Finally the GC-MS data were normalised to the internal standard succinic d4 acid to account for the 
technical variability associated with chemical derivatisation and low sample injection volumes. The 
chromatogram peaks areas were exported as an ASCII file into Microsoft Excel
®
 and these 52 metabolites 
were used for all further analyses. 
2.2. Software Tools 
All data analyses used in this work were conducted in R version 2.15.0 and 3.1.0; R is a software 
environment [30] that contains a variety of packages useful for data analysis and is a free open source 
program [30]. The following R packages were employed for visualization and statistical analysis; 
―chemometrics‖ [31] package has been used to determine the number of principal components (PCs) 
with cross-validation and for hierarchical cluster analysis (HCA) and picturing; ―MASS‖ package was used 
for linear discriminant analysis (LDA) [32]; ―rgl‖ package was applied as a 3D visualization device [33]; 
―mixOmics‖ [34] package was used to perform both PCA and partial least squares-discriminant analysis 
(PLS-DA); package ―impute‖ [35] which is a part of Bioconductor an open source and open development 
software project to provide tools for the analysis and comprehension of genomic data [36] was applied 
for substitution of missing values using kNN; and finally ―missForest‖ [23,37] for missing value 
imputation using RF. 
2.3. Data Preparation 
Data pre-treatment is a very important process because of its ability to make the data clearer and 
suited to analysis [38]. Here, we used autoscaling as it is the probably most reliable method [7,39]. 
This was conducted after replacing missing values. In autoscaling for each column (input feature) the 
mean value of that column is subtracted, followed by dividing the row entries for that column by the 
standard deviation within the same column. In other words, the aim of autoscaling is to break down 
relation with irregularities in order to produce slighter, well-structured relations, which in practice allow 
for better data recognition [39,40]. 
2.4. Imputation Methods 
In this study five different imputation methods of missing value were applied: zero, mean, median, 
kNN and RF. Zero imputation was used to replace all missing value with zeros. Mean imputation to 
replace the missing values with average value of corresponding metabolites (variables). The median 
imputation corresponds to central value of metabolite that split its values into two equal parts the 
higher and the lower part.  
2.4.1. Imputation of Missing Values Using k-Nearest Neighbours (kNN). 
kNN for each metabolite identifies missing values by recognizing the nearest neighbours of that 
feature using Euclidean distance [22]. The calculation takes into consideration that each candidate 
neighbours might miss some of the coordinates. As a result, the method uses the average distance from 
Metabolites 2014, 4 438 
 
 
the non-missing locations. As long as the k nearest neighbours for each metabolite is identified, the 
imputation of missing value is computed by averaging of non-missing values of its neighbours. Caution 
need to be taken when one want to deal with the cases where all of the neighbours are missing in  
a particular group. Nevertheless, this obstacle is circumvented by taking the overall column mean for 
that particular metabolite. Consequently, the technique has the ability to deal with the data set that 
contains large number of variables that include missing values [22]. 
2.4.2. Missing Value Imputation Using Random Forest (RF) 
RF is a classification and regression technique that can handle both parametric and non-parametric 
data sets of complex linear and non-linear problems [41]. The approach is based on the estimation  
of imputation error which is calculated for the bootstrapped samples and therefore no separate  
cross-validation is required. The process begins with splitting the missing data into training and test 
sets. The training set is used to generate a group of trees for the observed values in the training data set to 
predict the missing values. Consequently, the first step is to replace each of the missing data points from 
training set with a mean of the observed values for that variable. All missing values are replaced and the 
proximity matrix is calculated for first iteration set. The average weights calculated from the proximity 
matrix for first iteration are used to replace the missing values in the second iteration and so on until 
the stopping criterion is satisfied. The stopping criterion is passed based on the difference between the 
first and second iteration, then between second and third and so on. This is achieved when both differences 
have become larger once. As soon as this is accomplished the final matrix with replaced values is used 
to perform further analysis [23]. 
2.5. Unsupervised Learning 
Unsupervised learning algorithms attempt to find hidden structure in data, which displays any 
similarities between data points (e.g., metabolite levels), such as how close they are to each other and 
whether the data contain any outliers [42]. Additionally, these so-called exploratory methods are mainly 
based on cluster analysis. Cluster analysis aims to cluster data (i.e., samples) into constituent groups which 
describe common characteristics that they possess. These clusters should display high internal homogeneity 
within clusters (or as high as possible), and high external heterogeneity between clusters. 
2.5.1. Principal Components Analysis (PCA) 
The most frequently used exploratory analysis method is principal component analysis (PCA) which is 
used for computing linear latent variables (components). PCA is possibly one of the oldest and most 
well-known methods of multivariate data analysis (MVA) method which was invented in 1901 by Karl 
Pearson [43]. This technique is one of the simplest multivariate statistical procedures that reduce  
the dimensionality of data sets comprised of a large number of possibly correlated variables. On 
finding these correlated observations, Hotelling showed that PCA retains these features allowing any 
variability present in the data to be explained and visualized [44]. In general, the correlated original 
variables are transformed into a set of new uncorrelated variables, (principal components (PCs)), ordered 
according to their decreasing variance, whereby the first PCs describes more variability than any other 
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PC. The absence of correlation is a valuable property because it means that these indices (PCs) are 
assessing dissimilar correlations in the data [45]. 
Rather than generate a single PCA model we used k-fold cross-validation in order [46,47]: (i) to 
generate a generalized scree plot which allows us to assess random sampling of the population; and  
(ii) to calculate how many times the 3 groups were recovered (for this we calculate Q
2
 based on the test 
sets from the k-folds). Thus for PCA we applied 10-fold cross-validation and we repeated this 100 times. 
This allowed the explained variance for each model to be assessed. These was performed to determine 
the optimal number of PCs and from 1 to n PCs were used in this process and the overall percent 
explain variance represented as a box-whisker plot; further explanation of the PCA procedure can be 
found in supplementary information (SI). 
2.5.2. Hierarchical Cluster Analysis (HCA) 
There are numerous clustering approaches such as partitioning clustering which is stepwise process 
that work by partitioning observations, optimization-partitioning which allows for reassignment of 
objects to optimize an overall parameter, density or mode-seeking methods where cluster are created 
based on dense concentration of entities, and clumping with possible overlapping samples. However, in 
this study we have selected the most commonly used method, namely hierarchical clustering analysis 
(HCA) [48–50]. This approach is a fast and reliable technique, allowing for a huge amount of closely 
related samples or features to be organized into separated clusters [50]. 
Joining of clusters is based on similarities and dissimilarities in metabolites that allow for the separation 
of groups, with the most important factor in the creation of cluster beings the distance between two 
objects. Distances in clustering can be measured in various ways. One of the most common and frequently 
used is Euclidean distance. However, this can be only used to measure the distance between samples, 
but not a group of samples constructing clusters. Therefore, here in this study ―Ward‖ linkage was used 
to link groups of different clusters together and provides a clear visualization of the results [49–52]; further 
explanation of the HCA can be found in SI. 
In general, unsupervised learning is applied when there are no unlabeled training data (i.e., the 
modeling is performed on only the X data (SI)). On the other hand, there are supervised techniques that 
are mainly focused on classification of an input signal, which is to be defined as a member of predefined 
classes (so called Y data (SI)). 
2.6. Supervised Learning 
Supervised learning might be represented by a variety of methods and a particularly popular method 
used is discriminant analysis. By way of an example we can consider the scenario where we want to 
use supervised methods to classify whether cell samples under investigation by GC-MS metabolomics 
are cancerous or not. In this process a model is first constructed (calibrated) using a data training set  
of X data (metabolite levels) and Y data (cancer versus control) whose identities are unequivocally 
known. Obviously, it is essential to establish the training set prior to any analysis and this must be fully 
representative of the problem domain [53]. 
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2.6.1. Linear Discriminant Analysis (LDA) 
Linear discriminant analysis (LDA) (also known as discriminant function analysis (DFA)) [54] is  
a statistical tool for studying the association between a set of predictors versus a categorical response. 
This method aims to find the best linear separation between groups by determining the minimum 
dimensions at which groups can be separated. LDA is used in statistics as a dimensionality reduction 
technique in many classification problems, as well as being a useful variable selection method. In 
general, LDA is a procedure to find a linear combination of features, which describe or separate two or 
more groups of samples. In other words, LDA classifies data by providing more distinguishable classes 
using multivariate decision boundaries [54]. LDA can be used without prior PCA if the following 
condition is satisfied [38,55–57]:  
             (1) 
where Ns correspond to number of samples, Ng to the number of groups, and Nv reflects the number of 
inputs (features). 
However, LDA cannot be used with data which are highly collinear, such as is the case in the present 
study. Therefore, in this investigation PCA was performed prior to LDA to remove the effect of collinearity 
and reduce the number of variables in the X data matrix. 
2.6.2. Partial Least Squares-Discriminant Analysis (PLS-DA) 
Another widely used statistical tool for classification is partial least squares-discriminant analysis 
(PLS-DA) [58] which can be used either for both classification and variable selection [59]. The approach 
is an extension of the traditional PLS regression model which was developed for quantitative predictions. 
The main difference is that in PLS-DA, a ―dummy‖ response matrix was used to code multiple classes 
and the algorithm is calibrated to predict group membership. The maximum separation between classes 
(groups) is established by simultaneous rotation of the X and Y components [60,61]. 
2.7. Model Validation 
To assess the classification rates for PC-LDA and PLS-DA for each of the five missing value 
imputations we performed bootstrapping (with replacement). This approach proposed by Efron was 
used to minimize the risk of misrepresentative results as a single training set—test set split may not be 
sufficient enough to draw valid conclusions. Bootstrapping was performed 100 times and on average 
training sets will contain ~63.2% and test sets ~36.8% of all samples [62,63]. Therefore, the number  
of components for both PLS-DA and PC-LDA has been estimated based on percentage of correct 
classification in validation. 
3. Results and Discussion 
As discussed above in order to compare five different missing value substitutes we used data that 
had been generated from the metabolic profiling of MDA-MB-231 breast cancer cells cultured in three 
oxygen levels—normoxia, hypoxia and anoxia—that had been treated with 0.1 or 1 μM doxorubicin 
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drug, along with a control where no drug was used. Previously, for this data set the following analyses 
were performed: two-way ANOVA, PCA, PC-DFA, and correlation analysis [21,64]. 
In this study for the first approach we used the full data set which included all classes. These were  
3 aeration environments times 3 drug doses: (1) normoxia; (2) normoxia + 0.1 μM doxorubicin;  
(3) normoxia + 1 μM doxorubicin; (4) hypoxia; (5) hypoxia + 0.1 μM doxorubicin; (6) hypoxia + 1 μM 
doxorubicin; (7) anoxia; (8) anoxia + 0.1 μM doxorubicin; and finally (9) anoxia + 1 μM doxorubicin. 
Initially we looked at PCA and the discriminant analyses on these 9 groups. However, due to the relatively 
large number of groups this separation is very difficult to visualize as is illustrated in SI Figure S3.  
To try and uncouple the environment and the drug dosing we applied multiblock PCA (see SI for 
details) that should provide us with a graphical overview of separation between these two different 
projections [65]. However, this approach did not work very well (see SI Figure S4). Therefore, our 
analysis was performed for three different environments, as the effects of normoxia, hypoxia or anoxia 
were the dominating phenotype. 
Visualization of the scores generated from unsupervised and supervised methods is the main tool 
used in this study for evaluating the effect of the missing value substitutes (zero, mean, median, kNN 
and RF). The general idea being that for the three different groups these should group close to each 
other and away from the other groups. That is to say, (i) more compact clusters are more desirable; and 
(ii) the greater the distance between clusters is also a preferred outcome. 
For the first analysis we performed PCA and evaluated the total explained variance (TEV) captured 
in the principal components (PCs). Rather than doing this on all of the data in a single experiment we 
used 10-fold cross-validation, where 9 folds were used to generate each PCA and the 10th fold was left 
out, this was repeated until each fold had been left out once; this process was repeated 100 times with 
random splits into the 10 different partitions/folds. Figure 1 is a scree plot which illustrates how each 
of the different substitution can influence variance across the analysis. Here in this study 80% cut off 
point has been selected as criterion in estimation of the number of PCs to be used. However, this might 
vary from study to study and depends on the amount of information that needs to be included in the 
model. As can be observed in Figure 1 when RF was applied as a substitution of missing value only  
1–14 PCs were required to cover over 80% of explained variance. This result is followed by kNN 
method where 1–18 PCs where needed to cover similar level of explained variance. For zero replacement 
1–21 PCs were used to reach comparable level of variance this is followed by median with 1–27 PCs 
were required to cover 80% of explained variance, and the mean replacement approach required the 
highest number and the first 37 PCs (out of a possible 52) were needed to cover same level of variance. 
As ~15% of the data were zeros it is not surprising that such good results for zero were found as the 
variance will obviously be lower. What is interesting is that the median captures more variance than 
the mean imputation approach. Indeed this is very evident in just PC1 where for zero and median the 
first PCs characterize ~30% TEV whilst the mean explains <20%. Such a good results for RF might 
originate from the fact that the methods do not take into consideration the samples distributions. 
Having established the shape of the PCA plots for the five different imputation methods, the scores 
plots for PC1 vs. PC2 were generated when all the metabolomics data was used (Figure 2). 3D plots of 
PC1 vs. PC2 vs. PC3 are available in SI (Figure S5). Visual inspection of these PC scores plots indicates 
that despite some overall in all five plots, the separations is not quite as good for zero and mean imputation, 
whereas the median, kNN and RF replacement results in reasonably good separation between three groups. 
Metabolites 2014, 4 442 
 
 
Figure 1. Scree plot showing the effect of the five different missing value substitutes—zero 
(black boxplots), mean (red boxplots) and median (green boxplots), k-nearest neighbours 
(kNN) (blue boxplots) and RF (violet boxplots)—on the total explained variance recovered in 
principal component analysis (PCA). 10-fold cross-validation was repeated 100 times and 
the boxplots display statistical distribution among all 100 iterations. The arrows indicate 
the minimum number of components that are required to explain >80% variance. 
 
Figure 2. PCA scores plots showing comparisons of five different missing value substitutes on 
for: (A) zero; (B) mean; (C) median; (D) kNN; and (E) RF. Symbols represent: normoxia 
(black circles), hypoxia (red triangles) and anoxia (green pluses). 
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Figure 3 shows dendrograms based on Euclidean distance and ―Wards‖ linkage. Note that these 
dendrogram can be used to characterise particular clustering and the distance gives an element of 
multilevel hierarchy [49]. To identify grouping within the dendrogram we have coloured the text according 
to the atmospheric environment in which the cells were cultivated and used boxes to show where the 
majority of the same samples fall. 
Figure 3. HCA based on Wards linkage for five different value substitutes: (A) zero; (B) 
mean; (C) median; (D) kNN; and (E) random forest (RF). Boxes indicate where the majority 
of the following sample types are located. Text are coloured according to normoxia (black), 
hypoxia (red) or anoxia (green). 
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From the HCA we can see that different substitutes of missing values have a significant impact on 
clustering and it is clear than when the mean is used to replace the missing values that the clustering 
does not reflect the three expected groups. By contrast, all other replacement methods generate dendrograms 
that more-or-less recover the three environmental condition groups, with obvious exceptions that can 
be seen in Figure 3. This can also be observed in Table S1 (SI) that represent a purity measure of HCA; 
the percentage of samples coming from the same class as one cluster. 
Although PCA and HCA are useful because they are unsupervised analyses methods the interpretation 
is somewhat subjective as cluster plots and dendrograms are used. Moreover, the interpretation is after 
the cluster code is broken (i.e., the labels or colours are put onto the clusters) and this is not really appropriate 
for providing information about classification rate. Therefore, in the next step we investigated the impact 
of the different missing value replacements on supervised methods based on discriminant analyses. 
As described above bootstrapping was used to construct 100 different PC-LDA or PLS-DA models 
and inspection of these allows one to predict how accurate classification is. For PC-LDA this is in 
terms of recovery of test data with appropriate training data in LDA scores space, whilst for PLS-DA 
the Y predicted matrix is inspected and the binary encoding in this PLS2 model used. That is to say the 
encoding for normoxia is 100, hypoxia is 010 and for anoxia the output would be 001. Figure 4 
highlights how the different replacement approaches can have an impact on the average correct 
classification rates of the 100 models for PC-LDA (Figure 4A) and for PLS-DA (Figure 4B) and also 
shows the effect of the number of components used on this classification accuracy. To aid interpretation 
this plot is annotated with the points at which the highest classification occurs. For PC-LDA the 
preferred model is the one with RF imputation demonstrated an excellent classification rate of 98.02% 
with 22 latent variables. In addition, this method performed the best along all components in comparison 
to other replacement techniques. Second best result of 95.63% classification rate was recorded for 
kNN. Zero imputation as whilst this is slightly lower (92.02%) than the median imputation (92.57%), 
however fewer latent variables are used, 7 compared with 22 PCs. Whilst for PLS-DA both zero and 
median imputation give very similar predictive abilities (90.97% vs. 91.76%) and use a very similar 
number of latent variables (7 vs. 8). In terms of best performance for PLS-DA yet again RF (97.96%) 
and kNN (96.06%) accomplished the best in comparison to other methods; however the difference 
between both is smaller as for PC-LDA. What is clear from both PC-LDA and PLS-DA is that mean 
imputation (Figure 4) is significantly worse and predictions are only ~78%. However, these differences 
in classification rates are very small as it could be expected as these both methods should display 
similar results as reported in the literature [7,58,66,]. 
An additional output from PC-LDA is the scores plot which shows the best group separation, and 
Figure 5 shows LD1 vs. LD2 scores. It is clear that the 3 different groups of samples are generally well 
separated; however it is also clear that median and RF imputation have resulted in the best separation, 
followed by zero and kNN replacement and lastly mean substitutions for missing values. A very similar 
pattern can be observed for the PLS-DA where median seems to be the best substitute for missing 
value (data not shown). 
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Figure 4. Comparison of prediction accuracy for normoxia, hypoxia and anoxia when five 
different missing value substitutes (zero, mean, median, kNN and RF) are used in (A) principal 
component-linear discriminant analysis or (B) partial least squares-discriminant analysis. 
The results are displayed as an average percentage of correct classification in the test sets 
from 100 bootstraps versus the number of PCs used for. The arrows indicate first local 
maxima at which an optimum classification rate has been accomplished. Lines are coloured 
according to zero (black), mean (red), median (green), kNN (blue) or RF (violet) imputations. 
 
Figure 5. Principal components-linear discriminant analysis (PC-LDA) scores plots 
showing the comparison of the five different missing value substitutes—(A) zero; 
(B) mean; (C) median; (D) kNN and (E) RF—for the classification of normoxia (black 
circles), hypoxia (red triangles) and anoxia (green pluses). 
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4. Conclusions 
A summary of the class prediction results are shown in Table 1, and it is clear from this that RF 
performed the best. The RF imputation technique is followed by kNN, median and zero replacement 
methods that perform relatively well. By contrast, the mean imputation approach does not perform 
well which is an interesting observation, as this is the default method used by many researchers. An 
obvious question arises as to why this has been the case? 
Table 1. Comparison of different missing values substitutions used for discriminant analysis. 
   PC-LDA   PLS-DA 
 Zero Mean Median kNN RF Zero Mean Median kNN RF 
Classification rate (%) * 92.02 77.91 92.57 95.63 98.02 90.97 77.98 91.76 96.06 97.73 
Number of latent variables 
(components) used 
7 21 22 19 22 7 6 8 9 10 
* based on classifying normoxia, hypoxia and anoxia. 
The answer to the question is likely to be based on the concentration distribution profile of the 
metabolites collected. If a particular metabolite’s concentration follows a normal distribution then the 
mean imputation would be appropriate as the normal distribution has a Gaussian shape. Clearly in our 
case this is not the case as can be observed in Table 2. Almost half of the samples do not follow 
normal or near normal distribution as their values are highly positively or negatively skewed. Where 
for Normoxia samples the highest value (3.01) of positive skewness is recorded for galactose/glucose, 
followed by glycerol for Hypoxia with the highest value of 4.03 positive skewness, and finally benzoic 
acid with 4.15 positive skewness for Anoxia. Additional statistics such as percentage of missing 
values, mean, median, standard deviation, kurtosis and standard error can be found in Tables S2–S4. 
Table 2. Skewness of 3 aeration environments (Normoxia, Hypoxia, Anoxia) for 52 metabolites. 
Metabolite name Normoxia Hypoxia Anoxia 
Glycine –2.59 0.98 0.70 
Lactate –0.25 0.13 –0.35 
Pyruvate  0.14 0.25 1.54 
Valine  0.95 0.63 0.97 
Leucine  0.27 0.67 0.92 
Glycerol  0.59 4.03 1.45 
Isoleucine  0.12 1.29 1.05 
Leucine  1.15 2.07 1.80 
Malonate  –2.29 –0.61 –1.05 
Glycine  –0.55 0.03 –0.09 
Phosphate  1.29 0.78 1.01 
Threonine  –0.66 0.76 1.19 
Alanine  0.84 0.25 0.96 
Threonine  0.35 1.24 1.05 
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Table 2. Cont. 
Metabolite name Normoxia Hypoxia Anoxia 
Succinate  0.38 0.84 0.05 
Benzoic acid  –0.60 –1.06 4.15 
Threitol/erythritol  1.07 1.08 1.58 
Malate  –0.09 0.91 0.45 
4-hydroxyproline –0.54 2.65 0.98 
Aspartate 0.82 0.57 1.22 
4-aminobutyric acid  0.70 0.91 0.03 
Aspartate –0.33 1.99 –0.32 
4-hydroxyproline  0.10 0.00 0.86 
Xylitol 0.99 1.00 0.68 
2-hydroxyglutaric acid  0.89 1.24 0.22 
4-hydroxybenzoic acid  –0.78 1.26 1.71 
Methionine 0.18 1.23 1.10 
Creatinine  0.32 0.49 –0.55 
Putrescine 0.10 0.22 0.27 
Hypotaurine  –0.07 0.27 –0.62 
Glutamate 0.34 0.42 1.25 
2-oxoglutarate 0.32 0.36 0.56 
Fructose –0.20 0.46 2.00 
Sorbose/fructose  1.41 1.08 1.31 
Sorbitol/galactose /glucose  1.20 1.08 0.93 
Sorbose/fructose 1.55 1.56 1.34 
Glycerol 3-phosphate  –0.68 0.80 –0.20 
Galactose/glucose 2.28 1.33 1.99 
Galactose/glucose 2.36 0.35 2.21 
Galactose/glucose 3.01 1.52 1.97 
Citrate  0.50 1.17 0.46 
N-acetyl aspartate –0.90 0.59 0.78 
Glucose 2.15 0.63 2.39 
Scyllo-inositol 0.93 0.55 1.53 
Lysine  0.46 0.75 0.94 
Myo-inositol –1.65 0.29 –0.09 
Pantothenic acid 1.58 0.38 0.72 
Tyramine/tyrosine 0.82 0.85 1.04 
Hexadecanoic acid –0.86 1.57 1.57 
Octadecanoic acid –2.67 0.97 2.67 
Myo-inositol phosphate 0.81 0.84 2.78 
Lactose/maltose 0.33 1.21 0.83 
Different conclusions were given when mean and median imputations were compared recently  
for data generated from direct infusion Fourier transform ion cyclotron resonance mass spectrometry 
(DI-FT-ICR-MS) [8], where mean and median showed nearly same results. This suggests that these 
DI-FT-ICR-MS data may had been normally distributed with little or no skews or outliers in the metabolite 
concentrations [6]. However, in our study we have shown that metabolites that display skewness can 
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have a significant impact on the substitute of missing values and therefore, final output of the analysis. 
Where, skewness is an important feature that can articulate if the data are normally or near normally 
distributed where normal distribution has skewness of 0 or close to 0. As shown in this study not all 
metabolomics data follows normal distribution. Hence, we believe that careful analysis of distribution 
of the data prior to any analysis should be performed. Moreover, the authors recommended kNN, mean 
and median as imputation methods for missing values in metabolomics field. However, in our study we 
have shown that much better results can be accomplished when RF is used as a replacement method of 
missing values. 
We have demonstrated that the selection method chosen to replace missing values may have a dramatic 
impact on GC-MS based metabolomics data, both for unsupervised and supervised learning. Therefore, 
the handling of missing values is an absolutely vital step in data pre-processing, as has been suggested 
previously in the literature [7], to which special consideration should be given. Moreover, we have 
shown that selecting the median metabolite level as a substitute of missing values is a substantially better 
option than the selection of the mean metabolite response, which is sensitive to metabolite distribution 
when data are skewed, as shown in this study. As observed in [8] when metabolite levels are normally 
distributed then both mean and median imputations will provide very similar results, but one cannot be 
guaranteed that this is always be the case. The median is less vulnerable to outliers than the arithmetic 
mean and is therefore considered to be more robust [6]. We conclude that before doing a missing value 
imputation that the distribution of the data be examined; conducting a skewness calculation or more 
simply observing the ratio of the mean and median of the distribution could identify this. We therefore 
believe that an awareness of these factors needs to be concomitant with an understanding of the data 
themselves, prior to any data analysis when missing values are observed [13], else the conclusions  
of the study could be inaccurate. In summary, in the case of GC-MS metabolomics data studied here 
our findings recommend that RF should be favored as an imputation of missing value over the other 
tested methods, as this method provides more robust and trustful results. 
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